MedPath

IntraEpiGlioma

Recruiting
Conditions
C71
Malignant neoplasm of brain
Registration Number
DRKS00027365
Lead Sponsor
Klinik für Neurochirurgie am UKSH, Campus Kiel
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Suspected primary brain tumor or
brain metastasis

Exclusion Criteria

Other tumor entities

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
100 samples from different patients will be included to enable a valid assessment of the new diagnostic method. The number of patients should be reached around the end of 2023. The aim should be to obtain a valid molecular diagnosis during ongoing surgery.
Secondary Outcome Measures
NameTimeMethod
Recruiting till 2023
© Copyright 2025. All Rights Reserved by MedPath